Type:Notice
Citation:89 FR 106579
Reading Time:about a minute or two
Irvine Labs Inc. has applied to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of certain controlled substances. The application aims to facilitate research and development, as well as distribution to their research customers. The public can submit comments or objections about the application until February 28, 2025, via the Federal eRulemaking Portal. This notice was officially filed and noted by the DEA on December 27, 2024.
Simple Explanation
Irvine Labs Inc. wants to make and sell certain special medicines, but they need permission first. People can tell the government what they think about this until the end of February next year.